<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03020446</url>
  </required_header>
  <id_info>
    <org_study_id>Sorbion Study</org_study_id>
    <nct_id>NCT03020446</nct_id>
  </id_info>
  <brief_title>Effectiveness of Sorbion in the Treatment of Venous Leg Ulcers The Protocol Elements</brief_title>
  <acronym>Sorbion</acronym>
  <official_title>Effectiveness of Sorbion in the Treatment of Venous Leg Ulcers The Protocol Elements</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Toledo Health Science Campus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Toledo Health Science Campus</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To follow the effectiveness of Sorbion Dressing in the treatment of highly exuding venous leg&#xD;
      ulcers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Wounds will be assessed for inclusion into the study, digital images of the wound will be&#xD;
      taken, wound will be cleansed, a sorbion dressing will be placed on wound and a cover&#xD;
      dressing with be used to keep in place. The wound will be assessed and a dressing change will&#xD;
      take place weekly for 4 weeks. At the final visit a final wound evaluation will be done.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Provider of product no longer wished to continue with site. No data available.&#xD;
  </why_stopped>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">March 2016</completion_date>
  <primary_completion_date type="Actual">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Wound Size</measure>
    <time_frame>4 weeks</time_frame>
    <description>decreased wound bed measured in centimeters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound Maceration</measure>
    <time_frame>4 weeks</time_frame>
    <description>visual assessment of decreased wound maceration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Wound Necrosis</measure>
    <time_frame>4 weeks</time_frame>
    <description>visual assessment of decreased wound necrosis</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Venous Wound Ulcers</condition>
  <arm_group>
    <arm_group_label>Sorbion dressing to venous leg ulcer</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>any venous leg ulcer will receive sorbion dressing weekly for 4 weeks than wound will be assessed</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sorbion Dressing</intervention_name>
    <description>Sorbion dressing will be placed on venous leg ulcer and changed weekly for 4 weeks</description>
    <arm_group_label>Sorbion dressing to venous leg ulcer</arm_group_label>
    <other_name>Sorbion Sachet sorbion sana</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  venous leg ulcer&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  pregnant females&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Toledo Medical Center</name>
      <address>
        <city>Toledo</city>
        <state>Ohio</state>
        <zip>43614</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>October 7, 2015</study_first_submitted>
  <study_first_submitted_qc>January 11, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 13, 2017</study_first_posted>
  <results_first_submitted>November 3, 2020</results_first_submitted>
  <results_first_submitted_qc>November 3, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">November 27, 2020</results_first_posted>
  <last_update_submitted>November 3, 2020</last_update_submitted>
  <last_update_submitted_qc>November 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Ulcer</mesh_term>
    <mesh_term>Leg Ulcer</mesh_term>
    <mesh_term>Ulcer</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Sorbion Dressing to Venous Leg Ulcer</title>
          <description>any venous leg ulcer will receive sorbion dressing weekly for 4 weeks than wound will be assessed&#xD;
Sorbion Dressing: Sorbion dressing will be placed on venous leg ulcer and changed weekly for 4 weeks</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Sorbion Dressing to Venous Leg Ulcer</title>
          <description>any venous leg ulcer will receive sorbion dressing weekly for 4 weeks than wound will be assessed&#xD;
Sorbion Dressing: Sorbion dressing will be placed on venous leg ulcer and changed weekly for 4 weeks</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="67" lower_limit="62" upper_limit="76"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Wound Size</title>
        <description>decreased wound bed measured in centimeters</description>
        <time_frame>4 weeks</time_frame>
        <population>Study was terminated</population>
        <group_list>
          <group group_id="O1">
            <title>Sorbion Dressing to Venous Leg Ulcer</title>
            <description>any venous leg ulcer will receive sorbion dressing weekly for 4 weeks than wound will be assessed&#xD;
Sorbion Dressing: Sorbion dressing will be placed on venous leg ulcer and changed weekly for 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Wound Size</title>
          <description>decreased wound bed measured in centimeters</description>
          <population>Study was terminated</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wound Maceration</title>
        <description>visual assessment of decreased wound maceration</description>
        <time_frame>4 weeks</time_frame>
        <population>Study was termininated</population>
        <group_list>
          <group group_id="O1">
            <title>Sorbion Dressing to Venous Leg Ulcer</title>
            <description>any venous leg ulcer will receive sorbion dressing weekly for 4 weeks than wound will be assessed&#xD;
Sorbion Dressing: Sorbion dressing will be placed on venous leg ulcer and changed weekly for 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Wound Maceration</title>
          <description>visual assessment of decreased wound maceration</description>
          <population>Study was termininated</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Wound Necrosis</title>
        <description>visual assessment of decreased wound necrosis</description>
        <time_frame>4 weeks</time_frame>
        <population>Study was terminated</population>
        <group_list>
          <group group_id="O1">
            <title>Sorbion Dressing to Venous Leg Ulcer</title>
            <description>any venous leg ulcer will receive sorbion dressing weekly for 4 weeks than wound will be assessed&#xD;
Sorbion Dressing: Sorbion dressing will be placed on venous leg ulcer and changed weekly for 4 weeks</description>
          </group>
        </group_list>
        <measure>
          <title>Wound Necrosis</title>
          <description>visual assessment of decreased wound necrosis</description>
          <population>Study was terminated</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Sorbion Dressing to Venous Leg Ulcer</title>
          <description>any venous leg ulcer will receive sorbion dressing weekly for 4 weeks than wound will be assessed&#xD;
Sorbion Dressing: Sorbion dressing will be placed on venous leg ulcer and changed weekly for 4 weeks</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Munier Nazzal, MD</name_or_title>
      <organization>University of Toledo</organization>
      <phone>419-383-3576</phone>
      <email>Munier.Nazzal@utoledo.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

